Innospace Announces 80.8 Billion Won Rights Offering… Urgent Funding but Dilution and Failure Risks Remain

Innospace decides rights offering of 7 million common shares at 1st issue price of 11,540 won, total approx. 80.8 billion won.
Use of funds: debt repayment (bridge loan 10 billion) 10 billion, facility investment 6.65 billion, operating funds 64.13 billion (launch vehicle production, R&D, labor).
2025 consolidated net loss 75.1 billion won, 2026 Q1 net loss 12.5 billion won. Negative operating cash flow for 3 consecutive years.
First commercial launch (HANBIT-Nano) failed in Dec 2025 due to re-assembly issue. Target re-launch in Q3 2026 after corrective measures.
Largest shareholder stake 13.12% → diluted to 10.21% (assuming 5% subscription). Kolon group stake could reach 10.23%, potentially changing control.
Listed as tech growth company; risk of being designated as management item if sales <3 billion won after grace period. 2025 sales 2.75 billion won.
Financial stability: current ratio 151.86% (2026.1Q), debt ratio 44.02%, borrowing dependency 8.33% (favorable vs. industry avg.).
Plans 3 launches in 2026, expects turnaround to profit by 2028. High deviation from IPO forecasts (2024 sales deviation 99.3%).

Filing: [Correction of Description] Securities Registration Statement (Equity Securities)
Company: INNOSPACE (462350)
Submission: INNOSPACE Co., Ltd.
Receipt: 05-14-2026